share_log

Further Weakness as Der Future Science and Technology Holding Group (SZSE:002631) Drops 14% This Week, Taking Three-year Losses to 18%

Further Weakness as Der Future Science and Technology Holding Group (SZSE:002631) Drops 14% This Week, Taking Three-year Losses to 18%

隨着德爾未來科技控股集團(SZSE:002631)本週下跌14%,三年跌幅達到18%,進一步疲軟
Simply Wall St ·  01/24 01:07

It can certainly be frustrating when a stock does not perform as hoped. But no-one can make money on every call, especially in a declining market. While the Der Future Science and Technology Holding Group Co., Ltd. (SZSE:002631) share price is down 20% in the last three years, the total return to shareholders (which includes dividends) was -18%. That's better than the market which declined 27% over the last three years. Furthermore, it's down 18% in about a quarter. That's not much fun for holders. But this could be related to the weak market, which is down 9.2% in the same period.

當股票表現不如預期時,肯定會令人沮喪。但是,沒有人能在每次通話中賺錢,尤其是在下跌的市場中。儘管德爾未來科技控股集團有限公司(SZSE:002631)的股價在過去三年中下跌了20%,但股東總回報率(包括股息)爲-18%。這比過去三年下跌27%的市場要好。此外,它在大約一個季度內下降了18%。對於持有者來說,這沒什麼好玩的。但這可能與疲軟的市場有關,同期市場下跌了9.2%。

Given the past week has been tough on shareholders, let's investigate the fundamentals and see what we can learn.

鑑於過去一週對股東來說很艱難,讓我們調查一下基本面,看看我們能學到什麼。

See our latest analysis for Der Future Science and Technology Holding Group

查看我們對德爾未來科技控股集團的最新分析

There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.

不可否認,市場有時是有效的,但價格並不總是能反映潛在的業務表現。通過比較每股收益(EPS)和一段時間內的股價變化,我們可以了解投資者對公司的態度是如何隨着時間的推移而變化的。

Der Future Science and Technology Holding Group saw its share price decline over the three years in which its EPS also dropped, falling to a loss. Due to the loss, it's not easy to use EPS as a reliable guide to the business. However, we can say we'd expect to see a falling share price in this scenario.

在三年中,德爾未來科學與技術控股集團的股價下跌,每股收益也下降至虧損。由於虧損,使用EPS作爲可靠的業務指南並不容易。但是,我們可以說,在這種情況下,我們預計股價將下跌。

The graphic below depicts how EPS has changed over time (unveil the exact values by clicking on the image).

下圖描述了 EPS 隨着時間的推移是如何變化的(點擊圖片可以看到確切的值)。

earnings-per-share-growth
SZSE:002631 Earnings Per Share Growth January 24th 2024
SZSE: 002631 每股收益增長 2024 年 1 月 24 日

We're pleased to report that the CEO is remunerated more modestly than most CEOs at similarly capitalized companies. But while CEO remuneration is always worth checking, the really important question is whether the company can grow earnings going forward. Dive deeper into the earnings by checking this interactive graph of Der Future Science and Technology Holding Group's earnings, revenue and cash flow.

我們很高興地向大家報告,首席執行官的薪酬比資本相似公司的大多數首席執行官要適中。但是,儘管首席執行官的薪酬總是值得檢查的,但真正重要的問題是公司未來能否增加收益。查看這張德爾未來科技控股集團收益、收入和現金流的互動圖表,深入了解收益。

A Different Perspective

不同的視角

Although it hurts that Der Future Science and Technology Holding Group returned a loss of 9.8% in the last twelve months, the broader market was actually worse, returning a loss of 21%. Unfortunately, last year's performance may indicate unresolved challenges, given that it's worse than the annualised loss of 3% over the last half decade. Whilst Baron Rothschild does tell the investor "buy when there's blood in the streets, even if the blood is your own", buyers would need to examine the data carefully to be comfortable that the business itself is sound. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. To that end, you should be aware of the 1 warning sign we've spotted with Der Future Science and Technology Holding Group .

儘管德爾未來科技控股集團在過去十二個月中回報了9.8%的虧損令人痛心,但整個市場實際上更糟,回報了21%的虧損。不幸的是,去年的表現可能預示着尚未解決的挑戰,因爲它比過去五年中3%的年化虧損還要糟糕。儘管羅斯柴爾德男爵確實告訴投資者 “街上有血時買入,即使血液是你自己的”,但買家需要仔細檢查數據,以確定業務本身是健全的。我發現將長期股價視爲業務績效的代表非常有趣。但是,要真正獲得見解,我們還需要考慮其他信息。爲此,你應該注意我們在德爾未來科技控股集團發現的1個警告標誌。

For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

對於那些喜歡尋找中獎投資的人來說,這份最近有內幕收購的成長型公司的免費名單可能只是門票。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

請注意,本文引用的市場回報反映了目前在中國交易所交易的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論